Someone Just Bet Big on a Biotech Nobody's Watching

Hey there, it’s Brandon. 

Pull a thousand traders today and ask them what's on their radar for next week.

They'll tell you about Tesla earnings, Fed announcements, maybe some AI stock making headlines. You know what they won't mention?

ELDN.

Never heard of it? Neither had most people until the Ghost Prints Console lit up this morning.

Here's what caught my eye: Eledon Pharmaceuticals typically trades around 64 call contracts on an average day. Nothing special, right? Just another small biotech floating under the radar.

Today? Nearly 5,000 call contracts traded.

Click here to continue reading…